Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 100

Results For "standard"

1725 News Found

GeoVax secures multi-product license for ProBioGen's AGE1.CR.pIX suspension cell line
Drug Approval | September 27, 2023

GeoVax secures multi-product license for ProBioGen's AGE1.CR.pIX suspension cell line

The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types


Hermes Pharma to invest €25 million to bolster manufacturing capabilities
News | September 27, 2023

Hermes Pharma to invest €25 million to bolster manufacturing capabilities

The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing


Briefs: Mankind Pharma and Sequent Scientific
News | September 26, 2023

Briefs: Mankind Pharma and Sequent Scientific

Mankind Pharma commences the commercial operations newly set-up plant in Udaipur


Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
Clinical Trials | September 23, 2023

Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer

The companies will work with investigators to share the results with the scientific community


Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India
News | September 23, 2023

Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India

Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health


Apollo Telehealth revolutionizes healthcare access through innovation
Healthcare | September 20, 2023

Apollo Telehealth revolutionizes healthcare access through innovation

Apollo Telehealth has established more than 700 centers, in 7 states


Biovyn PVC to be used in sustainable prosthetics for the first time
News | September 20, 2023

Biovyn PVC to be used in sustainable prosthetics for the first time

Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy


Narayana Health unveils new brand identity
News | September 15, 2023

Narayana Health unveils new brand identity

The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity


Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
Policy | September 14, 2023

Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals

The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited